Bellevue Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-61
Closed -$1.07K 461
2023
Q3
$1.07K Hold
61
﹤0.01% 445
2023
Q2
$1.28K Sell
61
-100
-62% -$2.17K ﹤0.01% 452
2023
Q1
$3.79K Buy
161
+1
+0.6% +$27 ﹤0.01% 337
2022
Q4
$4.45K Hold
160
﹤0.01% 320
2022
Q3
$4K Sell
160
-19
-11% -$574 ﹤0.01% 332
2022
Q2
$6K Buy
179
+1
+0.6% +$35 ﹤0.01% 311
2022
Q1
$6K Hold
178
﹤0.01% 342
2021
Q4
$5K Hold
178
﹤0.01% 374
2021
Q3
$6K Hold
178
﹤0.01% 370
2021
Q2
$5K Buy
+178
New +$5.86K ﹤0.01% 387

Other funds holding OGN

Bellevue Asset Management's OGN Position: Q4 2023 in Review

Bellevue Asset Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 61 shares — an estimated $1.07K sold.

Bellevue Asset Management first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $6K in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Bellevue Asset Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Bellevue Asset Management sold 61 Organon & Co shares in Q4 2023, an estimated $1.07K.
  • Bellevue Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Bellevue Asset Management's Organon & Co position peaked at $6K in Q2 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Bellevue Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.